The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro
Abstract
Amyloid diseases are caused by the self-assembly of a given protein into an insoluble cross-beta-sheet quaternary structural form which is pathogenic. An understanding of the biochemical mechanism of amyloid fibril formation should prove useful in understanding amyloid disease. Toward this end, a procedure for the conversion of the amyloidogenic protein transthyretin into amyloid fibrils under conditions which mimic the acidic environment of a lysosome has been developed. Association of a structured transthyretin denaturation intermediate is sufficient for amyloid fibril formation in vitro. The rate of fibril formation is pH dependent with significant rates being observed at pHs accessible within the lysosome (3.6-4.8). Far-UV CD spectroscopic studies suggest that transthyretin retains its secondary structural features at pHs where fibrils are formed. Near-UV CD studies demonstrate that transthyretin has retained the majority of its tertiary structure during fibril formation as well. Near-UV CD analysis in combination with glutaraldehyde cross-linking studies suggests that a pH-mediated tetramer to monomer transition is operative in the pH range where fibril formation occurs. The rate of fibril formation decreases markedly at pHs below pH 3.6, consistent with denaturation to a monomeric TTR intermediate which has lost its native tertiary structure and capability to form fibrils. It is difficult to specify with certainty which quaternary structural form of transthyretin is the amyloidogenic intermediate at this time. These difficulties arise because the maximal rate of fibril formation occurs at pH 3.6 where tetramer, traces of dimer, and significant amounts of monomer are observed.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
ON THE BINDING OF CONGO RED BY AMYLOID
PUCHTLER, H., SWEAT, F., & LEVINE, M. (1962) · Journal of Histochemistry & Cytochemistry · doi:10.1177/10.3.355 · Cited by 1,128
Evidence that β-Amyloid Protein in Alzheimer's Disease Is Not Derived by Normal Processing
Sisodia, S. S., Koo, E. H., Beyreuther, K., Unterbeck, A., & Price, D. L. (1990) · Science · doi:10.1126/science.1691865 · Cited by 893
Blake, C. C. F., Geisow, M. J., Oatley, S. J., Rérat, B., & Rérat, C. (1978) · Journal of Molecular Biology · doi:10.1016/0022-2836(78)90368-6 · Cited by 791
Processing of the Amyloid Protein Precursor to Potentially Amyloidogenic Derivatives
Golde, T. E., Estus, S., Younkin, L. H., Selkoe, D. J., & Younkin, S. G. (1992) · Science · doi:10.1126/science.1738847 · Cited by 737
Fibril in senile systemic amyloidosis is derived from normal transthyretin.
Westermark, P., Sletten, K., Johansson, B., & Cornwell, G. G. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2843 · Cited by 696
Folding and association of proteins
Jaenicke, R. (1987) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(87)90011-3 · Cited by 691
Klunk, W. E., Pettegrew, J. W., & Abraham, D. J. (1989) · Journal of Histochemistry & Cytochemistry · doi:10.1177/37.8.2666510 · Cited by 623
Mechanism of acid-induced folding of proteins
Goto, Y., Takahashi, N., & Fink, A. L. (1990) · Biochemistry · doi:10.1021/bi00466a009 · Cited by 566
An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.
Kowall, N. W., Beal, M. F., Busciglio, J., Duffy, L. K., & Yankner, B. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7247 · Cited by 522
Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease
Joachim, C. L., Mori, H., & Selkoe, D. J. (1989) · Nature · doi:10.1038/341226a0 · Cited by 462
Saraiva, M. J., Birken, S., Costa, P. P., & Goodman, D. S. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111390 · Cited by 434
HIGH-RESOLUTION ELECTRON MICROSCOPIC ANALYSIS OF THE AMYLOID FIBRIL
Shirahama, T., & Cohen, A. S. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.33.3.679 · Cited by 383
Creation of "Amyloid" Fibrils from Bence Jones Proteins in vitro
Glenner, G. G., Ein, D., Eanes, E. D., Bladen, H. A., Terry, W., & Page, D. L. (1971) · Science · doi:10.1126/science.174.4010.712 · Cited by 377
β-PLEATED SHEET FIBRILS A COMPARISON OF NATIVE AMYLOID WITH SYNTHETIC PROTEIN FIBRILS
GLENNER, G. G., EANES, E. D., BLADEN, H. A., LINKE, R. P., & TERMINE, J. D. (1974) · Journal of Histochemistry & Cytochemistry · doi:10.1177/22.12.1141 · Cited by 290
Zettlmeissl, G., Rudolph, R., & Jaenicke, R. (1979) · Biochemistry · doi:10.1021/bi00592a007 · Cited by 280
Structure of human plasma prealbumin at 2.5 A resolution
Blake, C. C. F., Geisow, M. J., Swan, I. D. A., Rerat, C., & Rerat, B. (1974) · Journal of Molecular Biology · doi:10.1016/0022-2836(74)90291-5 · Cited by 275
LONDON, J., SKRZYNIA, C., & GOLDBERG, M. E. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03707.x · Cited by 197
Human amyloidosis, Alzheimer disease and related disorders.
Castaño, E. M., & Frangione, B. (1988) · PubMed · Cited by 178
Intralysosomal formation of amyloid fibrils.
Shirahama, T., & Cohen, A. S. (1975) · PubMed · Cited by 167
Solubilization of membrane proteins by sulfobetaines, novel zwitterionic surfactants
Gonenne, A., & Ernst, R. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90565-1 · Cited by 165
Amyloidosis: a final common pathway for protein deposition in tissues
Stone, M. (1990) · Blood · doi:10.1182/blood.v75.3.531.531 · Cited by 162
Wallace, M. R., Dwulet, F. E., Conneally, P. M., & Benson, M. D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112573 · Cited by 160
Deciphering Alzheimer's Disease: The Amyloid Precursor Protein Yields New Clues
Selkoe, D. J. (1990) · Science · doi:10.1126/science.2111582 · Cited by 141
Familial amyloidotic polyneuropathy
Benson, M. D., & Roudebush, R. L. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90162-8 · Cited by 125
Normal transthyretin and synthetic transthyretin fragments from amyloid-like fibrils in vitro
Gustavsson, Å., Engström, U., & Westermark, P. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91687-8 · Cited by 109
Amyloid enhancing factor-loaded macrophages in amyloid fibril formation.
Shirahama, T., Miura, K., Ju, S., Kisilevsky, R., Gruys, E., & Cohen, A. S. (1990) · PubMed · Cited by 105
Nilsson, S., Rask, L., & Peterson, P. A. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40795-3 · Cited by 99
Amyloidosis: a familiar problem in the light of current pathogenetic developments.
Kisilevsky, R. (1983) · PubMed · Cited by 83
[5] The measurement of cooperative protein self-assembly by turbidity and other techniques
Andreu, J. M., & Timasheff, S. N. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)30007-7 · Cited by 81
Saraiva, M. J., Costa, P., & Goodman, D. S. (1983) · PubMed · Cited by 80
Perry, K. M., Onuffer, J., Gittelman, M. S., et al. (1989) · Biochemistry · doi:10.1021/bi00445a061 · Cited by 62
Turkewitz, A. P., Schwartz, A. L., & Harrison, S. C. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37594-x · Cited by 51
Aging, Amyloid, and Alzheimer's Disease
Selkoe, D. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906013202209 · Cited by 41
Cited by
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Protein aggregation: folding aggregates, inclusion bodies and amyloid
Fink, A. L. (1998) · Folding and Design · doi:10.1016/s1359-0278(98)00002-9 · Cited by 1,157
The protofilament structure of insulin amyloid fibrils
Jiménez, J. L., Nettleton, E. J., Bouchard, M., Robinson, C. V., Dobson, C. M., & Saibil, H. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142459399 · Cited by 834
Metadata
- Authors
- Colon, W., & Kelly, J. W.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1992-09-15
- Volume
- 31
- Issue
- 36
- Pages
- 8654-8660
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2011606718
- Cited by
- 573
- References
- 34
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.